Tetra-Substituted Pyridinylimidazoles As Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase 3 for Potential Treatment of Neurodegenerative Diseases-Reference-Cited by-同舟云学术

Tetra-Substituted Pyridinylimidazoles As Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase 3 for Potential Treatment of Neurodegenerative Diseases

Published:2014-12-05 Issue:1 Volume:58 Page:443-456
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Muth Felix¹,Günther Marcel¹,Bauer Silke M.¹,Döring Eva¹,Fischer Sabine¹,Maier Julia²,Drückes Peter³,Köppler Jürgen³,Trappe Jörg³,Rothbauer Ulrich²,Koch Pierre¹,Laufer Stefan A.¹

Affiliation:

1. Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmaceutical Sciences, Eberhard Karls Universität Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany

2. Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstrasse 55, 72770 Reutlingen, Germany

3. Novartis Pharma AG, CH-4002 Basel, Switzerland

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm501557a

Reference27 articles.

1. Mammalian MAP kinase signalling cascades

2. Signal Transduction by the JNK Group of MAP Kinases

3. Emerging targets for anti-inflammatory therapy